What Daxor DXR is doing that could pay off big later Climbs 20260505 FGBIP First Q4 2025 EPS misses consensus estimates shares rise modestly on positive investor sentiment How Algorhythm Holdings RIME manages tail risk exposure Q4 2024 Earnings Fall Short WHWK Whitehawk Therapeutics falls 336 as Q4 2025 EPS misses estimates by a wide 1164 percent margin